background image

Paid Clinical Trials Spokane

Discover 297 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Chemotherapy with Endocrine Therapy

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Post Falls ID, Coeur d'Alene ID, Sandpoint ID, Walla Walla WAshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & Daratumumab

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Post Falls ID, Coeur d'Alene ID, Sandpoint ID, Walla Walla WAshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Selumetinib vs. Carboplatin/Vincristine

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Spokane WA, Seattle WA, Tacoma WA, Boise IDshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Tapinarof

Recruiting
PHASE3

Sponsor:

Dermavant Sciences, Inc.

Location:

Spokane WA, Calgary, Portland OR, Edmontonshow 14 more

Code:

NCT05172726

Conditions

Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

tapinarof cream, 1%

Camizestrant

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Spokane WA, Kelowna, Puyallup WA, Calgaryshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Milvexian

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Coeur d'Alene ID, Everett WA, Tacoma WA, Surreyshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Post Falls ID, Coeur d'Alene ID, Sandpoint ID, Walla Walla WAshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

Cretostimogene

Recruiting
PHASE3

Sponsor:

CG Oncology, Inc.

Location:

Spokane WA, Lakewood CO, Aurora CO, Lone Tree COshow 25 more

Code:

NCT04452591

Conditions

Non Muscle Invasive Bladder Cancer

High-grade Ta/ T1 Papillary Disease Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cretostimogene Grenadenorepvec

n-dodecyl-B-D-maltoside

Saruparib

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Spokane WA, Spokane Valley WA, Kelowna, Tacoma WAshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Zanubrutinib & Anti-CD20

Recruiting
PHASE3

Sponsor:

BeiGene

Location:

Spokane WA, Seattle WA, Puyallup WA, Vancouvershow 58 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab